Document:

EX-10.6

 Exhibit 10.6 

AMENDMENT NO. 1 TO THE AMENDED AND RESTATED 

EXCESS BENEFIT PLANOF ESB FINANCIAL CORPORATION 

This Amendment No. 1 to the Amended and Restated Excess Benefit Plan (the “Excess Benefit Plan”) of ESB Financial Corporation
(the “Company”) is dated and effective as of the 29th day of October 2014. The Excess Benefit Plan was originally effective as of October 30, 1996 and was last amended and restated effective as of November 20, 2007. Capitalized
terms which are not defined herein shall have the same meaning as set forth in the Excess Benefit Plan. 
 WHEREAS, the Company has
adopted the Excess Benefit Plan to enable certain key employees (the “Participants”) to receive benefits in excess of the limitations imposed by the Internal Revenue Code on tax-qualified plans; 

WHEREAS, the Company and its wholly owned subsidiary ESB Bank (the “Bank”) are entering into an Agreement and Plan of Merger
with Wesbanco, Inc. (“Wesbanco”) and Wesbanco Bank, Inc., which provides for the merger of the Company with and into Wesbanco (the “Merger”); 

WHEREAS, the Bank will pay special one-time bonuses to certain Participants in 2014 in connection with the Merger, and the Company
desires to amend the Excess Benefit Plan to exclude such bonuses when determining the amount of contributions to the Excess Benefit Plan; and 

WHEREAS, pursuant to the provisions of Section 7.1 of the Excess Benefit Plan, the Board may amend the Excess Benefit Plan at any
time. 
 NOW, THEREFORE, in consideration of the premises, the mutual agreements herein set forth, and such other consideration the
sufficiency of which is hereby acknowledged, the parties hereto hereby agree as follows: 
 1. Amendment to Section 3.1.
Section 3.1 of the Excess Benefit Plan is hereby amended to add the following paragraph at the end of such section: 

“Notwithstanding any provision in this Plan to the contrary, the calculation of the dollar amount of the Supplemental
Matching Contribution allocable to a Participant with respect to the 2014 Plan Year shall exclude the impact of cash bonuses which are identified by the Company or the Bank as special, one-time bonuses paid in 2014.” 

2. Amendment to Section 3.2. Section 3.2 of the Excess Benefit Plan is hereby amended to add the following paragraph at the
end of such section: 
 “Notwithstanding any provision in this Plan to the contrary, the calculation of the amount of
the Supplemental ESOP Allocation to be made by the Company or the Bank for the benefit of a Participant with respect to the 2014 Plan Year shall exclude the impact of cash bonuses which are identified by the Company or the Bank as special, one-time
bonuses paid in 2014.” 

 2. Effectiveness. This Amendment shall be deemed effective as of the date first written
above, as if executed on such date. Except as expressly set forth herein, this Amendment shall not by implication or otherwise alter, modify, amend or in any way affect any of the other terms, conditions, obligations, covenants or agreements
contained in the Excess Benefit Plan, all of which are ratified and affirmed in all respects and shall continue in full force and effect and shall be otherwise unaffected. 

3. Governing Law. This Amendment shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania.

 4. Counterparts. This Amendment may be executed in any number of counterparts, each of which shall for all purposes be deemed an
original, and all of which together shall constitute one and the same instrument. 
 (Signature page follows) 

  
 2 

 IN WITNESS WHEREOF, the Company has caused this Amendment to be executed effective as of
the day and year first written above. 
  

							
		 		 	ESB FINANCIAL CORPORATION
				
	Attest:	 		 		 	
				
	 /s/ Frank D. Martz
	 		 	By:	 	 /s/ William B. Salsgiver

	Frank D. Martz, Secretary	 		 		 	William B. Salsgiver, Chairman

  
 3PCRX - 9.30.14 - EX 10.1

Exhibit 10.1

CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR THE REDACTED PORTIONS OF THIS EXHIBIT.  THE REDACTIONS ARE INDICATED WITH “[**]”.  A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION.

SECOND AMENDMENT TO
COMMERCIAL OUTSOURCING SERVICES AGREEMENT
This Second Amendment to the Commercial Outsourcing Services Agreement (this "Agreement") is between Pacira Pharmaceuticals, Inc. (the "Company") and Integrated Commercialization Solutions, Inc. ("ICS").  This Amendment is effective as of August 25, 2014 (the "Amendment Effective Date").
RECITALS
		
	A.
	The Company and ICS are parties to a Commercial Outsourcing Services Agreement dated August 25, 2011, as amended by the First Amendment dated August 1, 2013 (as amended, the "Agreement");

		
	B.
	Pursuant to the Agreement, among other things, the Company engaged ICS to perform commercialization services for certain pharmaceutical products; and

		
	C.
	The parties now wish to amend the Agreement in certain respects.

AMENDMENT
NOW THEREFORE, the parties agree as follows:
		
	1.
	Defined Terms.  Capitalized terms in this Amendment that are not defined in this Amendment have the meanings given to them in the Agreement.  If there is any conflict between the Agreement and any provision of this Amendment, this Amendment will control.

		
	2.
	Term.  Section 4.1 of the Agreement is deleted in its entirety and replaced with the following:

Term.  This Agreement will be effective as of the Effective Date and will continue until August 25, 2017 (the "Term"), unless sooner terminated in accordance with the terms of this Agreement.  The Term may be extended upon written mutual agreement of the parties, such extension to be negotiated in good faith six (6) months prior to the expiration of the Term.
		
	3.
	Schedule B.  The parties agree that effective September 1, 2014, Schedule B to the Agreement is hereby deleted in its entirety and replaced with the attached Revised Schedule B.

		
	4.
	No Other Changes.  Except as otherwise provided in this Amendment, the terms and conditions of the Agreement will continue in full force.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the Amendment Effective Date.
	
		
	Pacira Pharmaceuticals, Inc.
By:  /s/ Kristen Williams
Name:  Kristen Williams
Title:  Vice President, General Counsel
	Integrated Commercialization Solutions, Inc.
By:  /s/ Stephen W. McKinnon
Name:  Stephen W. McKinnon
Title:  President

1

REVISED SCHEDULE B
ICS 3PL SCHEDULE OF FEES
	
			
	Fee
	Amount
	Description

	Monthly Management Fee

	 
Customer Service
 
Warehouse & Distribution
 
Returns Management
 
Finance
 
Information Technology & Reporting
 
Chargeback Management
 
Sample Management
 
Marketing Material Management

	 
$[**]
	 
[**]

2

[**] - Indicates certain information has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the redacted portions. 

	
			
	Sunday Shipments

	$[**]

	[**]

	Customer Service Fees

	 
EDI Order Processing Fees

Manual Order Processing Fees
	 
$[**]

$[**]

$[**]

$[**]

$[**]

$[**]
	 
[**]

[**]

	Customer Setup Fee
	$[**]
	[**]

	Account Maintenance / License Updates
	$[**]
	[**]

	Drop Shipment Surcharge
	$[**]
	[**]

3

[**] - Indicates certain information has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the redacted portions. 

	
			
	Fee
	Amount
	Description

	Allocation Fee
	$[**]

	[**]

	Rush Order
	$[**]

	[**]

	Emergency Order
	$[**]

	[**]

	International Order
	$[**]

	[**]

	Warehouse & Distribution Fees

	 
Product Storage - Refrigerated
	 
$[**]

$[**]

$[**]
	 
[**]

	Product Storage - Ambient
	$[**]
	[**]

4

[**] - Indicates certain information has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the redacted portions. 

	
			
	Fee
	Amount
	Description

	 
Trade Order Processing Fees
	 
$[**]

$[**]

$[**]

$[**]

$[**]

+
 
$[**]

$[**]

$[**]

$[**]

$[**]
	 
[**]

[**]

5

[**] - Indicates certain information has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the redacted portions. 

	
			
	Fee
	Amount
	Description

	Receiving Fee
	$[**]

	[**]

	Shipping Fee
	$[**]

	[**]

	Bulk Shipments
	$[**]

	[**]

	Packing Supplies
	$[**]

	[**]

	Freight
	$[**]

	[**]

	Finance

	Invoice Processing
	$[**]

	[**]

	Credit Verification Reports -     Dun & Bradstreet
	$[**]

	[**]

	Credit Verifications Reports - Experian
	$[**]

	[**]

	Returns Management

	RGA Initiation
	$[**]

	[**]

	Return Processing
	$[**]

	[**]

	Partial Returns Processing
	$[**]

	[**]

	Returns Storage
	$[**]

	[**]

	Contract and Chargeback Management

	Chargeback Processing -   Manual
	$[**]

	[**]

	Chargeback Processing - Electronic
	$[**]

	[**]

6

[**] - Indicates certain information has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the redacted portions. 

	
			
	Fee
	Amount
	Description

	Membership Additions
	$[**]

	[**]

	Contract Setup
	$[**]

	[**]

	Contract Updates
	$[**]

	[**]

	Information Technology and Reporting

	852/867; ABC, CAH, MCK
	$[**]

	[**]

	Custom Reports
	$[**]

	[**]

	Custom Development Services
	$[**]

	[**]

	Additional Fees

	Product Destruction
	$[**]

	[**]

	Telecom
	$[**]

	[**]

	FedEx/UPS/Postage Expenses
	$[**]

	[**]

	Pre-Approved Assessorial Labor Charge - Warehouse
	$[**]

	[**]

	Pre-Approved Assessorial Labor Charge - Office Staff
	$[**]

	[**]

	Pre-Approved Assessorial Labor Charge - QC, Management
	$[**]

	[**]

	ICS Travel
	$[**]

	[**]

7

[**] - Indicates certain information has been redacted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the redacted portions.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]